Needle in a Haystack Is for Financial Services Investors

For March 6, 2018, our forensic accounting red flag comes from a financial services firm with a hidden (and confusing) non-operating expense.

 

Check out our H2 hedge fund letters here.

pixel2013 / Pixabay

We pulled this highlight from yesterday’s research of 129 10-K filings, from which our Robo-Analyst technology collected 18,042 data points. Our analyst team used this data to make 2,644 forensic accounting adjustments with a dollar value of $153 billion. The adjustments were applied as follows:

  • 1,128 income statement adjustments with a total value of $15 billion
  • 1,088 balance sheet adjustments with a total value of $72 billion
  • 428 valuation adjustments with a total value of $67 billion

Figure 1: Filing Season Diligence for Tuesday, March 6th

Sources: New Constructs, LLC and company filings. 

We believe this research is necessary to fulfill the Fiduciary Duty of Care. Ernst & Young’s recent white paper, “Getting ROIC Right”, demonstrates how these adjustments contribute to meaningfully superior models and metrics.

Today’s Forensic Accounting Needle in a Haystack Is for Financial Services Investors

Analyst Peter Apockotos found an unusual item yesterday in CBIZ Inc.’s (CBZ) 10-K.

On page 25 of the footnotes (page 65 overall), CBZ disclosed a $12 million gain (24% of net income) on the investments in its deferred compensation plan. At first glance, it looks like this item is non-operating income and that we need to reduce reported pre-tax income by $12 million to get to the true operating cash flows (NOPAT).

However, the company clarifies its treatment of these deferred compensation gains on page 22. CBZ includes the $12 million gain under “Other Income” on the income statement, a line item we already exclude from our NOPAT calculation. In addition, the company records an offsetting $12 million increase to operating expenses. As a result, reported net income is unaffected, but reported operating income is significantly understated.

In 2017, CBZ’s reported operating income increased by just 1%. Our adjustments reveal that NOPAT actually increased by 14%.

This adjustment shows the importance of combining our Robo-Analyst technology with human subject matter experts. A sophisticated analyst that didn’t have the technology to rapidly identify this item would have to rely on the company’s understated operating income. An unsophisticated analyst that did have the technology to find this data point might mistake it for non-operating income and make an adjustment in the wrong direction. To get it right, you need have both man and machine working at a high level.

This article originally published on March 7, 2018.

Disclosure: David Trainer, Peter Apockotos, and Sam McBride receive no compensation to write about any specific stock, sector, style, or theme.

Follow us on Twitter (#filingseasonfinds), Facebook, LinkedIn, and StockTwits for real-time alerts on all our research.

Article by Sam McBride, New Constructs

LEAVE A COMMENT


Saved Articles
X
TextTExtLInkTextTExtLInk

The Life and Career of Charlie Munger

Charlie is more than just Warren Buffett’s friend and Berkshire Hathaway’s Vice Chairman – Buffett has actually credited him with redefining how he looks at investing. Now you can learn from Charlie firsthand via this incredible ebook and over a dozen other famous investor studies by signing up below:

  • Learn from the best and forever change your investing perspective
  • One incredible tidbit of knowledge after another in the page-turning masterpiece of a book
  • Discover the secrets to Charlie’s success and how to apply it to your investing
Never Miss A Story!
Subscribe to ValueWalk Newsletter. We respect your privacy.

Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Welcome in the new year by signing up up for ValueWalkPremium today and get our exclusive content for 40% off. This is our second biggest discount ever!!

Use coupon code VIP20 or click on the button below

Limited time offer only ENDS 1/31/2019 or after next 30 23 subscribers take advantage whichever comes first – please do not share this discount with others

 

0